IRF2 and acute myeloid leukemia: Exosomes originating from BMSCs translocate miR-222-3p to inhibitthe proliferation of AML cells by targeting interferon regulatory factor 2/inositolpolyphosphate 4-phosphatase type II (IRF2/INPP4B) [23].